Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
INVESTOR PRESENTATION - Regeneus Ltd
Health
Regeneus Limited (RGS) is a Sydney based regenerative medicine company, using stem cell and immuno-oncology technologies to develop a portfolio of cell-based therapies to address unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases.
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
announcement | t+2 movement | date |
---|---|---|
| +9.09% | 19 Nov 2020 |
| +9.09% | 19 Nov 2020 |
| +9.09% | 19 Nov 2020 |
| +9.09% | 19 Nov 2020 |
| +9.09% | 19 Nov 2020 |
| -4.17% | 10 Nov 2020 |
| -8.00% | 02 Nov 2020 |
| -8.00% | 01 Nov 2020 |
| -11.11% | 30 Oct 2020 |
| -11.11% | 30 Oct 2020 |
Current Price
52WK HIGH
52WK LOW
1YR RETURN
1YR RETURN VS. SECTOR
90 DAY RETURN
ASX RANK
/2,047
SECTOR RANK
/168
SHARES OUTSTANDING
Health
Regeneus Limited (RGS) is a Sydney based regenerative medicine company, using stem cell and immuno-oncology technologies to develop a portfolio of cell-based therapies to address unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases.
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
ASX:RGS is not raising right now
Want to invest?
(03) 9028 2888
clients@freshequities.com
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia